Mara Epstein to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Mara Epstein has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.488
-
Epstein MM, Divine G, Chao CR, Wells KE, Feigelson HS, Scholes D, Roblin D, Ulcickas Yood M, Engel LS, Taylor A, Fortuny J, Habel LA, Johnson CC. Statin use and risk of multiple myeloma: An analysis from the cancer research network. Int J Cancer. 2017 08 01; 141(3):480-487.
Score: 0.488